share_log

CRISPR Therapeutics | PRER14A: Preliminary revised proxy soliciting materials

Apr 29, 2019 07:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more